SIRT3 and familial pancreatic carcinoma: Besides, SIRT3 inhibits the aggregation of iron regulatory protein 1 (IRP1), and further reduces the transferrin receptor (TfR1) expression, thus, regulating cellular iron metabolism to affect the proliferation of pancreatic cancer cells (60).